Enzyme–substrate relationships in the ubiquitin system: approaches for identifying substrates of ubiquitin ligases

Cellular and Molecular Life Sciences

Volumn 74, Issue 18, 2017, Pages 3363-3375

  O’Connor, Hazel F ^a   Huibregtse, Jon M ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Cullin Ring ligases; E3 ubiquitin ligases; HECT E3s; RBR E3s; RING E3s

Indexed keywords

UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CO IMMUNOPRECIPITATION; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; ENZYME SUBSTRATE; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; UBIQUITINATION; CRISPR CAS SYSTEM; ENZYME SPECIFICITY; GENETICS; METABOLISM;

CRISPR-CAS SYSTEMS; HUMANS; IMMUNOPRECIPITATION; PROTEIN ARRAY ANALYSIS; SUBSTRATE SPECIFICITY; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 85018342631     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-017-2529-6     Document Type: Review

References (112)

1. Stewart MD, Ritterhoff T, Klevit RE, Brzovic PS (2016) E2 enzymes: more than just middle men. Nat Publ Gr 26:423–440. doi:10.1038/cr.2016.35
2. Finley D, Ulrich HD, Sommer T, Kaiser P (2012) The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics 192:319–360. doi:10.1534/genetics.112.140467
3. Li W, Bengtson MH, Ulbrich A et al (2008) Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle’s dynamics and signaling. PLoS One 3:e1487. doi:10.1371/journal.pone.0001487
4. Rotin D, Kumar S (2009) Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol 10:398–409. doi:10.1038/nrm2690
5. Buetow L, Huang DT (2016) Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat Rev Mol Cell Biol 17:626–642. doi:10.1038/nrm.2016.91
6. Ohi MD, Vander Kooi CW, Rosenberg JA et al (2003) Structural insights into the U-box, a domain associated with multi-ubiquitination. Nat Struct Biol 10:250–255. doi:10.1038/nsb906
7. Petroski MD, Deshaies RJ (2005) Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6:9–20. doi:10.1038/nrm1547
8. Sarikas A, Hartmann T, Pan Z-Q (2011) The cullin protein family. Genome Biol 12:220. doi:10.1186/gb-2011-12-4-220
9. Wang Z, Liu P, Inuzuka H, Wei W (2014) Roles of F-box proteins in cancer. Nat Rev Cancer 14:233–247. doi:10.1038/nrc3700
10. Satyanarayana A, Kaldis P (2009) Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28:2925–2939. doi:10.1038/onc.2009.170
11. Ingham RJ, Gish G, Pawson T (2004) The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture. Oncogene 23:1972–1984. doi:10.1038/sj.onc.1207436
12. Dastur A, Beaudenon S, Kelley M et al (2006) Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 281:4334–4338. doi:10.1074/jbc.M512830200
13. Pickrell AM, Youle RJ (2015) The roles of PINK1, Parkin, and mitochondrial fidelity in parkinson’s disease. Neuron 85:257–273. doi:10.1016/j.neuron.2014.12.007
14. Huibregtse J, Rohde JR, Martin G et al (2014) Hell’s BELs: bacterial E3 ligases that exploit the eukaryotic ubiquitin machinery. PLoS Pathog 10:e1004255. doi:10.1371/journal.ppat.1004255
15. Randow F, Lehner PJ (2009) Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11:527–534. doi:10.1038/ncb0509-527
16. Maculins T, Fiskin E, Bhogaraju S, Dikic I (2016) Bacteria-host relationship: ubiquitin ligases as weapons of invasion. Cell Res 26:499–510. doi:10.1038/cr.2016.30
17. Xu P, Duong DM, Seyfried NT et al (2009) Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137:133–145. doi:10.1016/j.cell.2009.01.041
18. Sasaki K, Iwai K (2015) Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system. Immunol Rev 266:175–189. doi:10.1111/imr.12308
19. Yau R, Rape M (2016) The increasing complexity of the ubiquitin code. Nat Cell Biol 18:579–586. doi:10.1038/ncb3358
20. Kim HC, Huibregtse JM (2009) Polyubiquitination by HECT E3s and the determinants of chain type specificity. Mol Cell Biol 29:3307–3318. doi:10.1128/MCB.00240-09
21. Christensen DE, Brzovic PS, Klevit RE (2007) E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol 14:941–948. doi:10.1038/nsmb1295
22. Jin L, Williamson A, Banerjee S et al (2008) Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133:653–665. doi:10.1016/j.cell.2008.04.012
23. Williamson A, Wickliffe KE, Mellone BG et al (2009) Identification of a physiological E2 module for the human anaphase-promoting complex. Proc Natl Acad Sci USA 106:18213–18218. doi:10.1073/pnas.0907887106
24. Garnett MJ, Mansfeld J, Godwin C et al (2009) UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit. Nat Cell Biol 11:1363–1369. doi:10.1038/ncb1983
25. Wu T, Merbl Y, Huo Y et al (2010) UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex. Proc Natl Acad Sci USA 107:1355–1360. doi:10.1073/pnas.0912802107
26. Hjerpe R, Hjerpe R, Aillet F et al (2009) Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep 10:1250–1258. doi:10.1038/embor.2009.192
27. Fortier JM, Kornbluth J (2006) NK lytic-associated molecule, involved in NK cytotoxic function, is an E3 ligase. J Immunol 176:6454–6463. doi:10.4049/jimmunol.176.11.6454
28. Gray WM, Del Pozo JC, Walker L et al (1999) Identification of an SCF ubiquitin-ligase complex required for auxin response in Arabidopsis thaliana. Genes Dev 13:1678–1691. doi:10.1101/gad.13.13.1678
29. Sun L, Shi L, Li W et al (2009) JFK, a Kelch domain-containing F-box protein, links the SCF complex to p53 regulation. Proc Natl Acad Sci USA 106:10195–10200. doi:10.1073/pnas.0901864106
30. Schwab M, Neutzner M, Möcker D, Seufert W (2001) Yeast Hct1 recognizes the mitotic cyclin Clb2 and other substrates of the ubiquitin ligase APC. EMBO J 20:5165–5175. doi:10.1093/emboj/20.18.5165
31. Deshaies RJ, Emberley ED, Saha A (2010) Control of cullin-ring ubiquitin ligase activity by Nedd8. In: Groettrup M (ed) Conjugation and deconjugation of ubiquitin family modifiers, vol 54. Springer, New York, pp 41–56
32. Vittal V, Stewart MD, Brzovic PS, Klevit RE (2015) Regulating the regulators: recent revelations in the control of E3 ubiquitin ligases. J Biol Chem 290:21244–21251. doi:10.1074/jbc.R115.675165
33. Cocklin R, Goebl M (2011) Nutrient sensing kinases PKA and sch9 phosphorylate the catalytic domain of the ubiquitin-conjugating enzyme Cdc34. PLoS One. doi:10.1371/journal.pone.0027099
34. Craney A, Kelly A, Jia L et al (2016) Control of APC/C-dependent ubiquitin chain elongation by reversible phosphorylation. Proc Natl Acad Sci. doi:10.1073/pnas.1522423113
35. Qiao R, Weissmann F, Yamaguchi M et al (2016) Mechanism of APC/CCDC20 activation by mitotic phosphorylation. Proc Natl Acad Sci USA. doi:10.1073/pnas.1604929113
36. Koyano F, Okatsu K, Kosako H et al (2014) Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510:162–166. doi:10.1038/nature13392
37. Kondapalli C, Kazlauskaite A, Zhang N et al (2012) PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol 2:120080. doi:10.1098/rsob.120080
38. Gallagher E, Gao M, Liu Y-C, Karin M (2006) Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc Natl Acad Sci USA 103:1717–1722. doi:10.1073/pnas.0510664103
39. Zhu F, Choi BY, Ma WY et al (2006) COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation. Cancer Res 66:5729–5736. doi:10.1158/0008-5472.CAN-05-4466
40. Strack P, Caligiuri M, Pelletier M et al (2000) SCF(beta-TRCP) and phosphorylation dependent ubiquitination of I kappa B alpha catalyzed by Ubc3 and Ubc4. Oncogene 19:3529–3536. doi:10.1038/sj.onc.1203647
41. 2 sensing. Science 292:464–468. doi:10.1126/science.1059817
42. Huibregtse JM, Yang JC, Beaudenon SL (1997) The large subunit of RNA polymerase II is a substrate of the Rsp5 ubiquitin-protein ligase. Proc Natl Acad Sci USA 94:3656–3661. doi:10.1073/pnas.94.8.3656
43. Chang A, Cheang S, Espanel X, Sudol M (2000) Rsp5 WW domains interact directly with the carboxyl-terminal domain of RNA polymerase II. J Biol Chem 275:20562–20571. doi:10.1074/jbc.M002479200
44. Beaudenon SL, Huacani MR, Wang G et al (1999) Rsp5 ubiquitin-protein ligase mediates DNA damage-induced degradation of the large subunit of RNA polymerase II in Saccharomyces cerevisiae. Mol Cell Biol 19:6972–6979
45. Peschiaroli A, Dorrello NV, Guardavaccaro D et al (2006) SCFTrCP-mediated degradation of claspin regulates recovery from the DNA replication checkpoint response. Mol Cell 23:319–329. doi:10.1016/j.molcel.2006.06.013
46. Gupta R, Kus B, Fladd C et al (2007) Ubiquitination screen using protein microarrays for comprehensive identification of Rsp5 substrates in yeast. Mol Syst Biol 3:116. doi:10.1038/msb4100159
47. Kus B, Gajadhar A, Stanger K et al (2005) A high throughput screen to identify substrates for the ubiquitin ligase Rsp5. J Biol Chem 280:29470–29478. doi:10.1074/jbc.M502197200
48. Merbl Y, Kirschner MW (2009) Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays. Proc Natl Acad Sci USA 106:2543–2548. doi:10.1073/pnas.0812892106
49. Stukenberg PT, Lustig KD, McGarry TJ et al (1997) Systematic identification of mitotic phosphoproteins. Curr Biol 7:338–348. doi:10.1016/S0960-9822(06)00157-6
50. Ayad NG, Rankin S, Ooi D et al (2005) Identification of ubiquitin ligase substrates by in vitro expression cloning. Methods Enzymol 399:404–414. doi:10.1016/S0076-6879(05)99028-9
51. McGarry TJ, Kirschner MW (1998) Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93:1043–1053. doi:10.1016/S0092-8674(00)81209-X
52. Zou H, McGarry TJ, Bernal T, Kirschner MW (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285:418–422. doi:10.1126/science.285.5426.418
53. Funabiki H, Murray AW (2000) The Xenopus chromokinesin Xkid is essential for metaphase chromosome alignment and must be degraded to allow anaphase chromosome movement. Cell 102:411–424. doi:10.1016/S0092-8674(00)00047-7
54. Ayad NG, Rankin S, Murakami M et al (2003) Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell 113:101–113. doi:10.1016/S0092-8674(03)00232-0
55. Rankin S, Ayad NG, Kirschner MW (2005) Sororin, a substrate of the anaphase- promoting complex, is required for sister chromatid cohesion in vertebrates. Mol Cell 18:185–200. doi:10.1016/j.molcel.2005.03.017
56. Hainline SG, Rickmyre JL, Neitzel LR et al (2014) The Drosophila MCPH1-B isoform is a substrate of the APCCdh1 E3 ubiquitin ligase complex. Biol Open 3:669–676. doi:10.1242/bio.20148318
57. Armacki M, Joodi G, Nimmagadda SC et al (2014) A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growth by regulating angiogenesis. Oncogene 33:1167–1180. doi:10.1038/onc.2013.43
58. Cryns VL, Byun Y, Rana A et al (1997) Specific proteolysis of the kinase protein kinase C-related kinase 2 by caspase-3 during apoptosis. Identification by a novel, small pool expression cloning strategy. J Biol Chem 272:29449–29453. doi:10.1074/jbc.272.47.29449
59. Lunardi A, Di Minin G, Provero P et al (2010) A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network. Proc Natl Acad Sci USA 107:6322–6327. doi:10.1073/pnas.1002447107447107
60. Benanti JA, Cheung SK, Brady MC, Toczyski DP (2007) A proteomic screen reveals SCFGrr1 targets that regulate the glycolytic-gluconeogenic switch. Nat Cell Biol 9:1184–1191. doi:10.1038/ncb1639
61. Chou DM, Xu Q, Yen H-CS et al (2008) Global protein stability profiling in mammalian cells. Science 322:918–923. doi:10.1126/science.1160489
62. Yen H-CS, Elledge SJ (2008) Identification of SCF ubiquitin ligase substrates by global protein stability profiling. Science 322:923–929. doi:10.1126/science.1160462
63. Emanuele MJ, Elia AEH, Xu Q et al (2011) Global identification of modular cullin-RING ligase substrates. Cell 147:459–474. doi:10.1016/j.cell.2011.09.019
64. Guruharsha KG, Rual J-F, Zhai B et al (2011) A protein complex network of Drosophila melanogaster. Cell 147:690–703. doi:10.1016/j.cell.2011.08.047
65. Kim W, Bennett EJ, Huttlin EL et al (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44:325–340. doi:10.1016/j.molcel.2011.08.025
66. Lister AL, Pocock M, Taschuk M, Wipat A (2009) Saint: a lightweight integration environment for model annotation. Bioinformatics 25:3026–3027. doi:10.1093/bioinformatics/btp523
67. Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009) Defining the human deubiquitinating enzyme interaction Landscape. Cell 138:389–403. doi:10.1016/j.cell.2009.04.042
68. Tagwerker C, Flick K, Cui M et al (2006) A tandem affinity tag for two-step purification under fully denaturing conditions. Mol Cell Proteomics 5:737–748. doi:10.1074/mcp.M500368-MCP200
69. Peng J, Schwartz D, Elias JE et al (2003) A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 21:921–926. doi:10.1038/nbt849
70. Xu G, Paige J, Jaffrey S (2010) Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinty profiling. Nat Biotechnol 28:868–873. doi:10.1038/nbt.1654.Global
71. Sarraf SA, Raman M, Guarani-Pereira V et al (2013) Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496:372–376. doi:10.1038/nature12043
72. Lee KA, Hammerle LP, Andrews PS et al (2011) Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J Biol Chem 286:41530–41538. doi:10.1074/jbc.M111.248856
73. Krönke J, Udeshi ND, Narla A et al (2014) Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343:301–305. doi:10.1126/science.1244851
74. Thompson JW, Nagel J, Hoving S et al (2014) Quantitative Lys-∊-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 Ligase HUWE1. J Biol Chem 289:28942–28955. doi:10.1074/jbc.M114.573352
75. Rose CM, Isasa M, Ordureau A et al (2016) Highly multiplexed quantitative mass spectrometry analysis of ubiquitylomes. Cell Syst. doi:10.1016/j.cels.2016.08.009
76. Scheffner M, Werness BA, Huibregtse JM et al (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136. doi:10.1016/0092-8674(90)90409-8
77. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495–505. doi:10.1016/0092-8674(93)90384-3
78. Jiang Y, Armstrong D, Albrecht U et al (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21:799–811. doi:10.1016/S0896-6273(00)80596-6
79. Martinez-Noël G, Galligan JT, Sowa ME et al (2012) Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes. Mol Cell Biol 32:3095–3106. doi:10.1128/MCB.00201-12
80. Talis AL, Huibregtse JM, Howley PM (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 273:6439–6445
81. Koepp D, Schaefer L, Ye X, Keyomarsi K (2001) Phosphorylation-dependent ubiquitination of Cyclin E by the SCF-Fbw7 ubiquitin ligase. Science 294:173–177. doi:10.1126/science.1065203
82. Nash P, Tang X, Orlicky S et al (2001) Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414:514–521. doi:10.1038/35107009
83. Welcker M, Singer J, Loeb KR et al (2003) Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell 12:381–392. doi:10.1016/S1097-2765(03)00287-9
84. Strohmaier H, Spruck CH, Kaiser P et al (2001) Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413:316–322. doi:10.1038/35095076
85. Welcker M, Clurman BE (2008) FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8:83–93. doi:10.1038/nrc2290
86. Davis MA, Larimore EA, Fissel BM et al (2013) The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with mediator. Genes Dev 27:151–156. doi:10.1101/gad.207720.112
87. Tan MKM, Lim HJ, Bennett EJ et al (2013) Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover. Mol Cell 52:9–24. doi:10.1016/j.molcel.2013.08.018
88. Bekker-Jensen S, Rendtlew Danielsen J, Fugger K et al (2010) HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat Cell Biol 12:12–80. doi:10.1038/ncb2008
89. Puffenberger EG, Jinks RN, Wang H et al (2012) A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder. Hum Mutat 33:1639–1646. doi:10.1002/humu.22237
90. Harlalka GV, Baple EL, Cross H et al (2013) Mutation of HERC2 causes developmental delay with Angelman-like features. J Med Genet 50:65–73. doi:10.1136/jmedgenet-2012-101367
91. Al-Hakim AK, Bashkurov M, Gingras AC et al (2012) Interaction proteomics identify NEURL4 and the HECT E3 ligase HERC2 as novel modulators of centrosome architecture. Mol Cell Proteomics 11:M111.014233. doi:10.1074/mcp.M111.014233
92. Danielsen JR, Povlsen LK, Villumsen BH et al (2012) DNA damage-inducible SUMOylation of HERC2 promotes RNF8 binding via a novel SUMO-binding Zinc finger. J Cell Biol 197:179–187. doi:10.1083/jcb.201106152
93. Galligan JT, Martinez-Noël G, Arndt V et al (2015) Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. J Proteome Res 14:953–966. doi:10.1021/pr501005v
94. Mellacheruvu D, Wright Z, Couzens AL et al (2013) The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods 10:730–736. doi:10.1038/nmeth.2557
95. Goldfarb D, Hast BE, Wang W, Major MB (2014) Spotlite: web application and augmented algorithms for predicting co-complexed proteins from affinity purification—mass spectrometry data. J Proteome Res 13:5944–5955. doi:10.1021/pr5008416
96. Mulvaney KM, Matson JP, Siesser PF et al (2016) Identification and characterization of MCM3 as a novel KEAP1 substrate. J Biol Chem. doi:10.1074/jbc.M116.729418
97. Aillet F, Lopitz-Otsoa F, Hjerpe R et al (2012) Isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. Methods Mol Biol 832:173–183. doi:10.1007/978-1-61779-474-2_12
98. Rubel CE, Schisler JC, Hamlett ED et al (2013) Diggin’ on U(biquitin): a novel method for the identification of physiological E3 ubiquitin ligase substrates. Cell Biochem Biophys 67:127–138. doi:10.1007/s12013-013-9624-6
99. Yoshida Y, Saeki Y, Murakami A et al (2015) A comprehensive method for detecting ubiquitinated substrates using TR-TUBE. Proc Natl Acad Sci USA 112:4630–4635. doi:10.1073/pnas.1422313112
100. Gao Y, Li Y, Zhang C et al (2016) Enhanced purification of ubiquitinated proteins by engineered tandem hybrid ubiquitin-binding domains (ThUBDs). Mol Cell Proteomics 15:1381–1396. doi:10.1074/mcp.M115.051839
101. Layfield R, Tooth D, Landon M et al (2001) Purification of poly-ubiquitinated proteins by S5a-affinity chromatography. Proteomics 1:773–777. doi:10.1002/1615-9861(200106)1:6<773:AID-PROT773>3.0.CO;2-0
102. Shi Y, Chan DW, Jung SY et al (2011) A data set of human endogenous protein ubiquitination sites. Mol Cell Proteomics 10:M110.002089. doi:10.1074/mcp.M110.002089
103. O’Connor HF, Lyon N, Leung JW et al (2015) Ubiquitin-activated interaction traps (UBAITs) identify E3 ligase binding partners. EMBO Rep 16:1699–1712. doi:10.15252/embr.201540620
104. Zhuang M, Guan S, Wang H et al (2013) Substrates of IAP ubiquitin ligases identified with a designed orthogonal E3 ligase, the NEDDylator. Mol Cell 49:273–282. doi:10.1016/j.molcel.2012.10.022
105. Roux KJ, Kim DI, Raida M, Burke B (2012) A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol 196:801–810. doi:10.1083/jcb.201112098
106. Roux KJ, Kim DI, Burke B (2013) BioID: a screen for protein-protein interactions. Curr Protoc Protein Sci. doi:10.1002/0471140864.ps1923s74
107. Coyaud E, Mis M, Laurent EMN et al (2015) BioID-based identification of Skp cullin F-box (SCF)β-TrCP1/2 E3 ligase substrates. Mol Cell Proteomics 14:1781–1795. doi:10.1074/mcp.M114.045658
108. Mark KG, Simonetta M, Maiolica A et al (2014) Ubiquitin ligase trapping identifies an SCFSaf1 pathway targeting unprocessed vacuolar/lysosomal proteins. Mol Cell 53:148–161. doi:10.1016/j.molcel.2013.12.003
109. Mark KG, Loveless TB, Toczyski DP (2016) Isolation of ubiquitinated substrates by tandem affinity purification of E3 ligase-polyubiquitin-binding domain fusions (ligase traps). Nat Protoc 11:291–301. doi:10.1038/nprot.2016.008
110. Iconomou M, Saunders DN (2016) Systematic approaches to identify E3 ligase substrates. Biochem J 473:4083–4101. doi:10.1042/BCJ20160719
111. O’Leary CE, Lewis EL, Oliver PM (2015) Ubiquitylation as a rheostat for TCR signaling: from targeted approaches toward global profiling. Front Immunol. doi:10.3389/fimmu.2015.00618
112. Scott DC, Rhee DY, Duda DM et al (2016) Two distinct types of E3 ligases work in unison to regulate substrate ubiquitylation. Cell 166(1198–1214):e24. doi:10.1016/j.cell.2016.07.027